Antony, France

Bérangère Thiers

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Sanofi-Aventis. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bérangère Thiers. Retrieved from https://idiyas.com/inventor/bérangère-thiers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bérangère Thiers: Innovator in Therapeutics

Introduction

Bérangère Thiers is a notable inventor based in Antony, France. He has made significant contributions to the field of therapeutics through his innovative research and development.

Latest Patents

Thiers holds a patent for "Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics." This patent discloses compounds according to a specific formula, detailing the various components involved. The disclosure also encompasses pharmaceutical compositions containing these compounds, processes for their preparation, and methods for their application in therapeutic settings. He has 1 patent to his name.

Career Highlights

Bérangère Thiers is associated with Sanofi-Aventis, a leading global biopharmaceutical company. His work focuses on developing innovative therapeutic solutions that address various medical needs.

Collaborations

Thiers has collaborated with esteemed colleagues, including Jozsef Zsolt Bocskei and Gary McCort, to advance his research and enhance the impact of his inventions.

Conclusion

Bérangère Thiers exemplifies the spirit of innovation in the pharmaceutical industry, contributing valuable inventions that have the potential to improve therapeutic outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…